Activist 13D/13G Filings - Lexeo Therapeutics Inc. (LXEO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-14
4:57 pm
Sale
13GLEXEO THERAPEUTICS INC
LXEO
CITADEL ADVISORS LLC2,084,267
7.8%
-8,221decrease
(-0.39%)
View
2024-02-14
4:43 pm
Purchase
13GLEXEO THERAPEUTICS INC
LXEO
Omega Fund VI L.P.2,157,623
8.1%
2,157,623increase
(New Position)
View
2024-02-14
4:34 pm
Purchase
13GLEXEO THERAPEUTICS INC
LXEO
Lundbeckfond Invest A/S1,835,959
6.9%
1,835,959increase
(New Position)
View
2024-02-14
1:43 pm
Purchase
13GLEXEO THERAPEUTICS INC
LXEO
JANUS HENDERSON GROUP PLC
JHG
2,330,738
8.7%
2,330,738increase
(New Position)
View
2024-02-14
06:04 am
Purchase
13GLEXEO THERAPEUTICS INC
LXEO
D1 Capital Partners L.P.2,506,607
9.4%
2,506,607increase
(New Position)
View
2024-02-13
4:43 pm
Purchase
13GLEXEO THERAPEUTICS INC
LXEO
Longitude Capital Partners IV LLC2,567,100
9.6%
2,567,100increase
(New Position)
View
2023-12-15
4:51 pm
Purchase
13GLEXEO THERAPEUTICS INC
LXEO
Novo Holdings A/S1,307,829
4.9%
13,776increase
(+1.06%)
View
2023-12-11
5:13 pm
Purchase
13GLEXEO THERAPEUTICS INC
LXEO
EVENTIDE ASSET MANAGEMENT LLC3,002,831
11.93%
3,002,831increase
(New Position)
View
2023-11-24
4:33 pm
Purchase
13GLEXEO THERAPEUTICS INC
LXEO
Novo Holdings A/S1,294,053
5.1%
1,294,053increase
(New Position)
View
2023-11-17
4:23 pm
Purchase
13GLEXEO THERAPEUTICS INC
LXEO
CITADEL ADVISORS LLC2,092,488
8.3%
2,092,488increase
(New Position)
View